-
Glow More Chemo
In the Kay Research and Care Center, children can change the lighting in their hospital rooms from sunny yellow to jungle green; mandarin orange to purple pizzazz. It’s one way kids can exert a little control during a tumultuous time.
-
Medulloblastoma: The Pieces Snap Together
St. Jude scientists discover genes suspected to cause brain tumors in children. This discovery lays the foundation to expand targeted treatments.
-
Medulloblastoma: DNA Points the Way
Find out about how the discovery of 6 inherited gene mutations in medulloblastoma prompted the proposed guidelines for genetic counseling and testing when treating this type of brain cancer.
-
Accelerating Progress Through Global Collaboration
St. Jude prepares to greatly increase the number of children treated on clinical trials such as SJMB12.
-
St. Jude Proton Therapy: Think Positive
St. Jude opens the first proton therapy center designed just for children.
-
An Added Boost for Medulloblastoma: SJELIOT
SJELIOT, a St. Jude-led clinical trial for medulloblastoma, tests prexasertib, a drug that enhances the power of other chemotherapies.
-
Together: Powered by St. Jude
A new website brings families and St. Jude experts together to face pediatric cancer. This online resource offers trustworthy resources for families around the world to learn about childhood cancer.
-
Radiation and Ependymoma: The Sweet Taste of Success
With more than a decade of follow-up, results from a newly published clinical trial show that radiation after surgery triples survival for kids with ependymoma.
-
DIPG: Focused Steps
St. Jude clinical trial tests chemotherapy that crosses the blood-brain barrier to reach a deadly brain tumor.
-
Reading Skills: Windows to the World
By pinpointing cognitive skills necessary for reading, scientists work to improve quality of life for hearing-impaired brain tumor survivors.